Literature DB >> 15047193

Fusogenic domain and lysines in saposin C.

Xiaoyang Qi1, Zhengtao Chu.   

Abstract

Saposin C, a sphingolipid activator protein with fusogenic activity, interacts specifically with the membrane containing negatively charged, unsaturated phospholipids. The kinetics and mechanism of saposin C-induced membrane fusion were previously investigated using acidic phospholipid liposomes. A hypothetic clip-on model for such a fusion process was illustrated by the ionic binding between saposin C and lipids, as well as the inter-saposin C hydrophobic interaction. Here, we report the location of the fusogenic domain in a linear sequence at the amino-terminal half of saposin C. This domain consisted of the first and second helical sequences. Selected positively charged lysines in the fusogenic domain were mutated to study the roles of basic residues in the saposin C-induced vesicle fusion. Based on the results, Lys13 and Lys17 were critical for the fusogenic activity, but had no effect on the enzymatic activation of acid beta-glucosidase (GCase). These results clearly indicate the segregation of the fusion and activation function into two different regions of saposin C. Interestingly, all the Lys mutant saposin Cs anchored on the acidic phospholipid membrane. Our data suggest that saposin C's fusogenic and activation functions have different requirements for the orientation and insertion manners of helical peptides in membranes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047193     DOI: 10.1016/j.abb.2004.02.023

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  19 in total

Review 1.  A short guided tour through functional and structural features of saposin-like proteins.

Authors:  Heike Bruhn
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

2.  Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine.

Authors:  Patrick M Winter; John Pearce; Zhengtao Chu; Christopher M McPherson; Ray Takigiku; Jing-Huei Lee; Xiaoyang Qi
Journal:  J Magn Reson Imaging       Date:  2014-05-06       Impact factor: 4.813

3.  Crystal structures of saposins A and C.

Authors:  Victoria E Ahn; Paul Leyko; Jean-René Alattia; Lu Chen; Gilbert G Privé
Journal:  Protein Sci       Date:  2006-07-05       Impact factor: 6.725

4.  Saposin C coupled lipid nanovesicles enable cancer-selective optical and magnetic resonance imaging.

Authors:  Vinod Kaimal; Zhengtao Chu; Yonatan Y Mahller; Brigitte Papahadjopoulos-Sternberg; Timothy P Cripe; Scott K Holland; Xiaoyang Qi
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

5.  Toll-like receptor 4 can recognize SapC-DOPS to stimulate macrophages to express several cytokines.

Authors:  Kaihua Lu; Guangfeng Zhao; Hongna Lu; Shuli Zhao; Yuxian Song; Xiaoyang Qi; Yayi Hou
Journal:  Inflamm Res       Date:  2010-09-19       Impact factor: 4.575

Review 6.  The immunological functions of saposins.

Authors:  Alexandre Darmoise; Patrick Maschmeyer; Florian Winau
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

7.  Cytotoxicity and Selectivity in Skin Cancer by SapC-DOPS Nanovesicles.

Authors:  Shadi Abu-Baker; Zhengtao Chu; Ashley M Stevens; Jie Li; Xiaoyang Qi
Journal:  J Cancer Ther       Date:  2012-08

8.  Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion.

Authors:  Misbaudeen Abdul-Hammed; Bernadette Breiden; Matthew A Adebayo; Jonathan O Babalola; Günter Schwarzmann; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2010-02-23       Impact factor: 5.922

9.  Membrane-spanning lipids for an uncompromised monitoring of membrane fusion and intermembrane lipid transfer.

Authors:  Günter Schwarzmann; Bernadette Breiden; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2015-08-11       Impact factor: 5.922

10.  Pancreatic cancer: current standards, working towards a new therapeutic approach.

Authors:  Olugbenga Olowokure; Xiaoyang Qi
Journal:  Expert Rev Anticancer Ther       Date:  2014-03-13       Impact factor: 4.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.